Movatterモバイル変換


[0]ホーム

URL:


AU2436792A - Quinazoline derivatives as inhibitors of hiv reverse transcriptase - Google Patents

Quinazoline derivatives as inhibitors of hiv reverse transcriptase

Info

Publication number
AU2436792A
AU2436792AAU24367/92AAU2436792AAU2436792AAU 2436792 AAU2436792 AAU 2436792AAU 24367/92 AAU24367/92 AAU 24367/92AAU 2436792 AAU2436792 AAU 2436792AAU 2436792 AAU2436792 AAU 2436792A
Authority
AU
Australia
Prior art keywords
inhibitors
reverse transcriptase
hiv reverse
quinazoline derivatives
quinazoline
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU24367/92A
Inventor
Susan F. Britcher
Mark E. Goldman
Joel R. Huff
William C. Lumma
Terry A. Lyle
Linda S Payne
Martha L Quesada
William M Sanders
Philip E. Sanderson
Thomas J. Tucker
Steven D. Young
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck and Co IncfiledCriticalMerck and Co Inc
Publication of AU2436792ApublicationCriticalpatent/AU2436792A/en
Abandonedlegal-statusCriticalCurrent

Links

Classifications

Landscapes

AU24367/92A1991-08-161992-08-06Quinazoline derivatives as inhibitors of hiv reverse transcriptaseAbandonedAU2436792A (en)

Applications Claiming Priority (6)

Application NumberPriority DateFiling DateTitle
US74644591A1991-08-161991-08-16
US7464451991-08-16
US84587592A1992-03-031992-03-03
US8458751992-03-03
US88012192A1992-05-071992-05-07
US8801211992-05-07

Publications (1)

Publication NumberPublication Date
AU2436792Atrue AU2436792A (en)1993-03-16

Family

ID=27419344

Family Applications (1)

Application NumberTitlePriority DateFiling Date
AU24367/92AAbandonedAU2436792A (en)1991-08-161992-08-06Quinazoline derivatives as inhibitors of hiv reverse transcriptase

Country Status (2)

CountryLink
AU (1)AU2436792A (en)
WO (1)WO1993004047A1 (en)

Families Citing this family (57)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
US5646154A (en)*1992-10-071997-07-08Sumitomo Pharmaceuticals Co., Ltd.Pharmaceutical compositions for inhibiting the formation of tumor necrosis factor
ATE174908T1 (en)*1993-05-261999-01-15Sumitomo Pharma QUINAZOLINONE DERIVATIVES
US5426230A (en)*1993-08-271995-06-20Merck & Co., Inc.Process for the preparation of 4-chloro-2-cyclopropylcarbonylaniline
US5747498A (en)1996-05-281998-05-05Pfizer Inc.Alkynyl and azido-substituted 4-anilinoquinazolines
GB9626643D0 (en)*1996-12-211997-02-12Astra Pharma ProdCompounds
HRP980143A2 (en)*1997-04-091999-02-28Soo Sung Ko4,4-disubstituted-3,4-dihydro-2 (1h)-quinazolinones useful as hiv reverse transcriptase inhibitors
US6124302A (en)1997-04-092000-09-26Dupont Pharmaceuticals4,4-disubstituted-3,4-dihydro-2(1H)-quinazolinones useful as HIV reverse transcriptase inhibitors
AU3199099A (en)*1998-03-271999-10-18Du Pont Pharmaceuticals Company4,4-disubstituted-3,4-dihydro-2(1h)-quinazolinthione derivatives, their preparation and their use as hiv reverse transcriptase inhibitors
US6077981A (en)*1998-08-282000-06-20Eastman Chemical CompanyProcess for the production of cyclopropylmethyl halides
AU5588400A (en)*1999-05-262000-12-18Du Pont Pharmaceuticals Company1,4-benzodiazepin-2-ones useful as hiv reverse transcriptase inhibitors
US6191306B1 (en)*1999-08-032001-02-20Eastman Chemical CompanyProcess for the preparation of cyclopropylglycine
US6593337B1 (en)1999-10-192003-07-15Bristol-Myers Squibb Pharma CompanyTricyclic compounds useful as HIV reverse transcriptase inhibitors
US6175009B1 (en)1999-11-182001-01-16Dupont Pharmaceuticals CompanyProcess for the preparation of quinazolinones
US6207854B1 (en)1999-12-152001-03-27Eastman Chemical CompanyPreparation of 3-amino-3-cyclopropylpropanoate esters
US6596729B2 (en)*2000-07-202003-07-22Bristol-Myers Squibb CompanyTricyclic-2-pyridone compounds useful as HIV reverse transcriptase inhibitors
US6946469B2 (en)2001-03-282005-09-20Bristol-Myers Squibb Pharma CompanyCyanamide, alkoxyamino, and urea derivatives of 4,4-disubstituted-3,4-dihydro-2(1H)-quinazolinones as HIV reverse transcriptase inhibitors
US7015214B2 (en)2001-03-282006-03-21Bristol-Myers Squibb Pharma CompanyCyanamide, alkoxyamino, and urea derivatives of 1,3-benzodiazepine as HIV reverse transcriptase inhibitors
US6825210B2 (en)2001-04-192004-11-30Bristol-Myers Squibb Pharma CompanyTricyclic compounds useful as HIV reverse transcriptase inhibitors
AR040456A1 (en)2002-06-272005-04-06Bristol Myers Squibb Co PIRIDINE N-OXIDES 2,4-USEFUL DISPOSALS AS INHIBITORS OF REVERSE TRANSCRIPTASE OF THE HUMAN IMMUNODEFICIENCY VIRUS
MX2007010965A (en)2005-03-092007-09-19Merck & Co IncQuinazolinone t-type calcium channel antagonists.
KR20080029965A (en)*2005-06-142008-04-03쉐링 코포레이션 Aspartyl Protease Inhibitor
CA2610815A1 (en)2005-06-142006-12-28Schering CorporationAspartyl protease inhibitors
AR054620A1 (en)2005-06-142007-07-04Schering Corp ASPARTIL PROTEASAS INHIBITORS
AR056865A1 (en)2005-06-142007-10-31Schering Corp NITROGEN HETEROCICLES AND ITS USE AS INHIBITORS OF PROTEASES, PHARMACEUTICAL COMPOSITIONS
AR054510A1 (en)2005-06-142007-06-27Schering Corp HETEROCICLICAL COMPOUNDS AS INHIBITORS OF ASPARTIL PROTEASAS AND PHARMACEUTICAL COMPOSITIONS THAT UNDERSTAND THEM.
US8686002B2 (en)2005-08-212014-04-01AbbVie Deutschland GmbH & Co. KGHeterocyclic compounds and their use as binding partners for 5-HT5 receptors
MX2009006228A (en)2006-12-122009-06-22Schering CorpAspartyl protease inhibitors.
CN101225083A (en)*2007-01-162008-07-23北京摩力克科技有限公司Tetrahydro quinazoline ketone compound and use thereof in preparation of medicine treating and preventing virus diseases
WO2009044788A1 (en)*2007-10-052009-04-09Banyu Pharmaceutical Co., Ltd.Benzoxazinone derivative
CA2705318C (en)*2007-11-152013-12-31Boehringer Ingelheim International GmbhInhibitors of human immunodeficiency virus replication
EP2574610A1 (en)*2007-11-152013-04-03Gilead Sciences, Inc.Inhibitors of human immonodeficiency virus replication
ES2463720T3 (en)*2007-11-162014-05-29Gilead Sciences, Inc. Human immunodeficiency virus replication inhibitors
SG185995A1 (en)2007-11-162012-12-28Gilead Sciences IncInhibitors of human immunodeficiency virus replication
EP2485920B1 (en)2009-10-082016-04-27Merck Sharp & Dohme Corp.Pentafluorosulfur imino heterocyclic compounds as bace-1 inhibitors, compositions, and their use
US8557826B2 (en)2009-10-082013-10-15Merck Sharp & Dohme Corp.Pentafluorosulfur imino heterocyclic compounds as BACE-1 inhibitors, compositions, and their use
WO2011044187A1 (en)2009-10-082011-04-14Schering CorporationIminothiadiazine dioxide compounds as bace inhibitors, compositions, and their use
UA108363C2 (en)2009-10-082015-04-27 IMINOTIADIASIADIOXIDE OXIDES AS BACE INHIBITORS, COMPOSITIONS THEREOF AND THEIR APPLICATIONS
US8440693B2 (en)2009-12-222013-05-14Novartis AgSubstituted isoquinolinones and quinazolinones
CU24130B1 (en)2009-12-222015-09-29Novartis Ag ISOQUINOLINONES AND REPLACED QUINAZOLINONES
WO2012138590A1 (en)2011-04-072012-10-11Merck Sharp & Dohme Corp.Pyrrolidine-fused thiadiazine dioxide compounds as bace inhibitors, compositions, and their use
EP2694489B1 (en)2011-04-072017-09-06Merck Sharp & Dohme Corp.C5-c6 oxacyclic-fused thiadiazine dioxide compounds as bace inhibitors, compositions, and their use
CN103874496A (en)2011-08-222014-06-18默沙东公司 2-spiro-substituted iminothiazines as BACE inhibitors and their mono- and dioxide-oxides, compositions and uses thereof
WO2013175417A1 (en)2012-05-242013-11-28Novartis AgPyrrolopyrrolidinone compounds
EP2948453B1 (en)2013-01-222017-08-02Novartis AGPyrazolo[3,4-d]pyrimidinone compounds as inhibitors of the p53/mdm2 interaction
US9403827B2 (en)2013-01-222016-08-02Novartis AgSubstituted purinone compounds
WO2014191894A1 (en)2013-05-272014-12-04Novartis AgImidazopyrrolidinone derivatives and their use in the treatment of disease
EP3004112B1 (en)2013-05-282017-08-30Novartis AGPyrazolo-pyrrolidin-4-one derivatives and their use in the treatment of disease
US9624247B2 (en)2013-05-282017-04-18Novartis AgPyrazolo-pyrrolidin-4-one derivatives as bet inhibitors and their use in the treatment of disease
EP3071571A1 (en)2013-11-212016-09-28Novartis AGPyrrolopyrrolone derivatives and their use as bet inhibitors
HK1255074A1 (en)2015-07-012019-08-02Crinetics Pharmaceuticals, Inc.Somatostatin modulators and uses thereof
WO2017070680A1 (en)2015-10-222017-04-27Cavion LlcMethods for treating angelman syndrome and related disorders
WO2018152317A1 (en)2017-02-152018-08-23Cavion, Inc.Calcium channel inhibitors
JP7321097B2 (en)2017-04-262023-08-04カビオン・インコーポレイテッド Methods for Improving Memory and Cognition and Treating Memory and Cognitive Impairments
WO2019023278A1 (en)2017-07-252019-01-31Crinetics Pharmaceuticals, Inc.Somatostatin modulators and uses thereof
WO2020072773A1 (en)2018-10-032020-04-09Cavion, Inc.Treating essential tremor using (r)-2-(4-isopropylphenyl)-n-(1-(5-(2,2,2-trifluoroethoxy)pyridin-2-yl)ethyl)acetamide
WO2021007487A1 (en)2019-07-112021-01-14Praxis Precision Medicines, Inc.Formulations of t-type calcium channel modulators and methods of use thereof
CN116375653B (en)*2023-03-312025-02-25常州大学 A method for synthesizing chiral tetrahydroquinazoline derivatives with high enantioselectivity

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
CH515911A (en)*1968-07-011971-11-30Sandoz Ag Process for the preparation of 3,4-dihydro-4-phenyl-2 (1H) -quinazolinones
FR2027023A1 (en)*1968-12-241970-09-25Farmaceutici ItaliaSubstd quinazoline derivs prepn cns depress - ants
CA986932A (en)*1970-08-271976-04-06Shigeho InabaProcess for preparing quinazoline derivatives
US3764600A (en)*1970-10-061973-10-09Sandoz Ag1-substituted-quinazoline-2(1h)-thiones
DE2162327C3 (en)*1970-12-231975-09-18Sumitomo Chemical Co., Ltd., Osaka (Japan) Process for the preparation of 3,4-Oihydro-2 (1 H) -quinazolinones
SU470423A1 (en)*1973-06-271975-05-15Центральное Проектно-Конструкторское Бюро Главтехмонтажа Министерства Монтажных И Специальных Строительных Работ Ссср Device for winding the cable carrier cable on the anchor drum
JPS5251379A (en)*1975-10-241977-04-25Sumitomo Chem Co LtdPreparation 3,4-dihydro-2(1h)-quinazoline derivates
US4490374A (en)*1982-09-301984-12-25Ortho Pharmaceutical Corporation5,6-Dialkoxy-3,4-optionally substituted-2(1H)quinazolinones, composition and method of use
JPH0747582B2 (en)*1989-12-111995-05-24杏林製薬株式会社 Quinazoline-3-alkanoic acid derivative and its salt and process for producing the same

Also Published As

Publication numberPublication date
WO1993004047A1 (en)1993-03-04

Similar Documents

PublicationPublication DateTitle
AU2436792A (en)Quinazoline derivatives as inhibitors of hiv reverse transcriptase
AU2216292A (en)Inhibitors of hiv reverse transcriptase
AU641769B2 (en)Inhibitors of HIV reverse transcriptase
AU1046895A (en)New quinazolines as inhibitors of hiv reverse transcriptase
AU1694295A (en)Benzoxazinones as inhibitors of hiv reverse transcriptase
AU8596191A (en)Hydroxylated inhibitors of hiv reverse transcriptase
AU8693491A (en)Synergism of hiv reverse transcriptase inhibitors
PL310410A1 (en)Inhibitors of reverse hiv transcriptase
AU1677092A (en)Tetrahydroxyalkane derivatives as inhibitors of hiv aspartyl protease
HU9400258D0 (en)Quinazoline derivatives as acetylcholinesterase inhibitors
FI950508L (en) Benzoxazinones as HIV reverse transcriptase inhibitors
AU2407492A (en)Compounds and methods for inhibition of hiv and related viruses
AU5958394A (en)Coumarin derivatives as retroviral inhibitors
AU635415B2 (en)Use of n-alkyl-lactams as crystallization inhibitors
AU4829793A (en)Quinazoline derivatives
AU3841393A (en)New quinazolines as inhibitors of HIV reverse transcriptase
AU7845191A (en)Inhibitors of HIV reverse transcriptase
AU4488989A (en)Phenanthrolinedicarboxylate esters, 4-aminoquinoline and isoquinoline derivatives as inhibitors of hiv reverse transcriptase
GB9420287D0 (en)3-substituted heterocyclic indoles as inhibitors of HIV reverse transcriptase
ZA926130B (en)Quinazoline derivatives as inhibitors of hiv reverse transcriptase
GB9308781D0 (en)Inhibitors of hiv reverse transcriptase
ZA933179B (en)New quinazolines as inhibitors of hiv reverse transcriptase.
ZA926708B (en)Inhibitors of hiv reverse transcriptase
ZA914653B (en)Inhibitors of hiv reverse transcriptase
ZA935724B (en)Benzoxazinones as inhibitors of HIV reverse transcriptase

[8]ページ先頭

©2009-2025 Movatter.jp